Unknown

Dataset Information

Environment-responsive nanophores for therapy and treatment monitoring via molecular MRI quenching.


ABSTRACT: The effective delivery of therapeutics to disease sites significantly contributes to drug efficacy, toxicity and clearance. Here we demonstrate that clinically approved iron oxide nanoparticles (Ferumoxytol) can be utilized to carry one or multiple drugs. These so called 'nanophores' retain their cargo within their polymeric coating through weak electrostatic interactions and release it in slightly acidic conditions (pH 6.8 and below). The loading of drugs increases the nanophores' transverse T2 and longitudinal T1 nuclear magnetic resonance (NMR) proton relaxation times, which is proportional to amount of carried cargo. Chemotherapy with translational nanophores is more effective than the free drug in vitro and in vivo, without subjecting the drugs or the carrier nanoparticle to any chemi

SUBMITTER: Kaittanis C 

PROVIDER: S-EPMC4108301 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature